Adjuvant Rituximab - exploratory trial in young people with Graves' disease.

Tim CheethamMichael Cole Mario Abinun Amit AllahabadiaTim BarrattJustin Huw Davies Paul Dimitri Amanda Jane Drake Zainaba Mohamed Robert D MurrayCaroline SteeleNicola Zammitt Sonya CarnellJonathan PrichardGillian C Watson Sophie Hambleton John N S Matthews Simon H S Pearce

Published in: The Journal of clinical endocrinology and metabolism (2021)

Adjuvant rituximab, administered with a 12 month course of ATD, may increase the likelihood of remission in young people with Graves' hyperthyroidism. A randomised trial of adjuvant rituximab in young people with Graves' hyperthyroidism is warranted.

Keyphrases

diffuse large b cell lymphoma
early stage
chronic lymphocytic leukemia
hodgkin lymphoma
study protocol
middle aged
clinical trial
randomized controlled trial
phase iii
phase ii
systemic lupus erythematosus
ulcerative colitis